News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

261,504 Results

Type

Article (13668)
Company Profile (110)
Press Release (247726)

Section

Business (88063)
Career Advice (461)
Deals (15342)
Drug Delivery (66)
Drug Development (36610)
Employer Resources (49)
FDA (6278)
Job Trends (6190)
News (150265)
Policy (14041)

Tag

Date

Last 7 days (326)
Last 30 days (1136)
Last 365 days (12666)
2024 (11446)
2023 (14263)
2022 (19583)
2021 (20115)
2020 (19065)
2019 (14908)
2018 (11743)
2017 (13924)
2016 (13175)
2015 (15517)
2014 (12430)
2013 (10609)
2012 (11405)
2011 (11934)
2010 (10901)

Location

Africa (314)
Arizona (40)
Asia (19833)
Australia (2561)
California (980)
Canada (582)
China (108)
Colorado (40)
Connecticut (40)
Europe (38891)
Florida (141)
Illinois (111)
Indiana (83)
Kansas (51)
Maryland (153)
Massachusetts (856)
Minnesota (57)
New Jersey (410)
New York (268)
North Carolina (275)
Northern California (420)
Pennsylvania (275)
South America (500)
Southern California (430)
Texas (128)
Washington State (70)

Filters

Type

Article (13668)
Company Profile (110)
Press Release (247726)

Section

Business (88063)
Career Advice (461)
Deals (15342)
Drug Delivery (66)
Drug Development (36610)
Employer Resources (49)
FDA (6278)
Job Trends (6190)
News (150265)
Policy (14041)

Tag

Date

Last 7 days (326)
Last 30 days (1136)
Last 365 days (12666)
2024 (11446)
2023 (14263)
2022 (19583)
2021 (20115)
2020 (19065)
2019 (14908)
2018 (11743)
2017 (13924)
2016 (13175)
2015 (15517)
2014 (12430)
2013 (10609)
2012 (11405)
2011 (11934)
2010 (10901)

Location

Africa (314)
Arizona (40)
Asia (19833)
Australia (2561)
California (980)
Canada (582)
China (108)
Colorado (40)
Connecticut (40)
Europe (38891)
Florida (141)
Illinois (111)
Indiana (83)
Kansas (51)
Maryland (153)
Massachusetts (856)
Minnesota (57)
New Jersey (410)
New York (268)
North Carolina (275)
Northern California (420)
Pennsylvania (275)
South America (500)
Southern California (430)
Texas (128)
Washington State (70)

261,504 Results for "teva pharmaceuticals".

Sort By

Earnings

Teva Reports Strong Generics Demand in Q3, Expects Higher 2024 Revenue

Driven by copycat versions of Bristol Myers Squibb’s Revlimid and Novo Nordisk’s Victoza, Teva’s generics business was again a top-performer in the third quarter, with U.S. sales growing 30% and bringing in $1.1 billion in sales.

November 7, 2024
·
2 min read
·
Tristan Manalac
Legal

Teva to Pay $450M in Settlement With DOJ Over Kickback and Price-Fixing Allegations

The U.S. Department of Justice alleged that Teva violated the Anti-Kickback Statute and the False Claims Act. The payment is in addition to the criminal penalty paid by Teva USA under its deferred prosecution agreement.

October 11, 2024
·
2 min read
·
Tristan Manalac
Pharm Country

Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.

June 24, 2024
·
9 min read
Business

Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations

Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.

May 15, 2024
·
7 min read
Policy

Teva Loses Inhaler Patent Case Against Amneal, Must Delete or Amend Orange Book Listing

Teva Pharmaceuticals lost its patent row with Amneal Pharmaceuticals on Monday as a New Jersey court ruled that some of Teva’s claims over its inhaler product ProAir HFA were improperly listed on the FDA’s Orange Book.

June 12, 2024
·
2 min read
·
Tristan Manalac
Policy

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. today announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd., alleging infringement of U.S. Patent Numbers 9,040,074 (“the ’074 patent”) and 9,950,069.

April 3, 2024
·
9 min read
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024.

June 4, 2024
·
2 min read
Teva to Present at the 2024 Bank of America Healthcare Conference

Teva Pharmaceutical Industries Ltd. announced that Richard Francis, Teva’s President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024.

May 2, 2024
·
2 min read
Policy

FTC Investigates Teva Over Refusal to Remove Improperly Listed Patents from Orange Book

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company allegedly ignored directives to withdraw or amend contentious patent listings on the FDA’s Orange Book.

July 2, 2024
·
1 min read
·
Tristan Manalac
Policy

Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade

Teva Pharmaceuticals has settled years of tax litigation with the Israel Tax Authority for $750 million, which the company will pay in installments starting in 2024 to 2029.

June 26, 2024
·
2 min read
·
Tristan Manalac

1 of 26,151

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin